Skip to content

Chronic Obstructive Pulmonary Diseases and Proprioceptive Neuromuscular Facilitation

The Effect of Resistant Proprioceptive Neuromuscular Facilitation Exercises on Respiratory Muscle Strength in Chronic Obstructive Pulmonary Diseases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05723302
Enrollment
31
Registered
2023-02-10
Start date
2017-01-20
Completion date
2022-12-01
Last updated
2023-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD

Brief summary

To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.

Detailed description

The study was carried out between January 2017 and January 2019, with patients followed up with the diagnosis of COPD in Çanakkale Mehmet Akif Ersoy State Hospital and Çanakkale Onsekiz Mart University Medical Faculty Hospital, Department of Chest Diseases. It was approved by Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Date: 30.12.2016, Decision No. 573) and was done in accordance with the Declaration of Helsinki. All participants were informed about the purpose of the study, the total duration of treatment and the applications to be made, and a consent form was signed. The study was conducted as a prospective and randomized controlled study, and inclusion and exclusion criteria were determined. Thirty-five patients diagnosed with COPD were referred to the study, four patients were excluded because they did not meet the inclusion criteria, and the study was conducted with a total of 31 participants. The 31 patients included in the study were randomized after their initial evaluation and divided into two groups as experimental and control groups. Patients meeting the inclusion criteria were divided into 2 groups. Randomized by ordering by date of application.

Interventions

DIAGNOSTIC_TESTMIP/MEP

MIP/MEP

Sponsors

Mehmet Akif Ersoy Canakkale State Hospital
CollaboratorOTHER_GOV
Çanakkale Onsekiz Mart University
CollaboratorOTHER
Istanbul Medipol University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
38 Years to 67 Years
Healthy volunteers
Yes

Inclusion criteria

* To be diagnosed with stage 1, stage 2 and stage 3 COPD according to GOLD (Global Initiative for Obstructive Lung Diseases) criteria * Having FEV1/FVC \<70% according to pulmonary function test * Being clinically stable * Being over 18 years old * Volunteer to participate in the program

Exclusion criteria

* Having a COPD exacerbation in the last 8 weeks * To have participated in a regular exercise training program in the last 1 year * Having a musculoskeletal disease and neuromuscular disease that may prevent exercise * Inability to cooperate for pulmonary function test and respiratory muscle strength measurement * Being on long-term oxygen therapy

Design outcomes

Primary

MeasureTime frameDescription
HADS10 minutesHospital Anxiety Depression Scale

Secondary

MeasureTime frameDescription
SGRQ15 minutesSt George's Respiratory Questionnaire

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026